Dana Farber Cancer Institute /ID# 155361

Boston, Massachusetts 02215

We've found

1 trials

at this facility

A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Subjects With Relapsed/Refractory Myelodysplastic Syndromes (MDS)

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Boston, MA

Use our guide to learn which trials are right for you!